{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:48:40Z","timestamp":1761061720481,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologie"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Die Myokarditis und die inflammatorische Kardiomyopathie sind aufgrund ihrer unterschiedlichen Ausl\u00f6ser, Ph\u00e4notypen und Stadien diagnostisch h\u00e4ufig schwer zu diagnostizieren.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodische Innovationen und Probleme<\/jats:title>\n                <jats:p>Die kardiale Positronen-Emissions-Tomographie\/Magnetresonanztomographie (PET\/MRT) zeichnet sich neben der myokardialen Gewebecharakterisierung mittels MRT durch den m\u00f6glichen Nachweis einer aktiven myokardialen Entz\u00fcndung (Inflammation) mittels PET aus. Die Kombination von MRT und PET ist somit eher synergistisch als rein summativ: Die m\u00f6glicherweise in der MRT vorhandenen kardialen Ver\u00e4nderungen lassen sich durch die PET in aktive inflammatorische (und somit noch potenziell reversible) Prozesse oder \u00e4ltere chronische (irreversible) Narben unterscheiden. Die kardiale Sarkoidose mit einem potenziellen Nebeneinander von aktiven und chronischen Ver\u00e4nderungen bietet sich an, um die St\u00e4rken einer hybriden PET\/MRT zur Geltung bringen zu lassen. Wichtig f\u00fcr eine aussagekr\u00e4ftige kardiale PET ist eine gute Vorbereitung mit Low-Carb-Di\u00e4t, um eine suffiziente Suppression der myokardialen Glukoseaufnahme zu gew\u00e4hrleisten.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Empfehlungen<\/jats:title>\n                <jats:p>Die Diagnostik einer inflammatorischen Herzerkrankung sowie deren Charakterisierung in akut vs. chronische Prozesse gelingt mit der kardialen Hybrid-PET\/MRT, wie am Beispiel der kardialen Sarkoidose gezeigt werden konnte.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00117-022-01064-w","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T16:03:27Z","timestamp":1662134607000},"page":"954-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hybrid-PET\/MRT bei inflammatorischer Kardiomyopathie","Hybrid PET\/MRI for inflammatory cardiomyopathy"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1705-8439","authenticated-orcid":false,"given":"Patrick","family":"Krumm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4844-5442","authenticated-orcid":false,"given":"Simon","family":"Greulich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-0417","authenticated-orcid":false,"given":"Christian","family":"la Foug\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2668-7325","authenticated-orcid":false,"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"1064_CR1","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1007\/s00330-017-5008-4","volume":"28","author":"F Nensa","year":"2018","unstructured":"Nensa\u00a0F, Bamberg\u00a0F, Rischpler\u00a0C et\u00a0al (2018) Hybrid cardiac imaging using PET\/MRI: a\u00a0joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM). Eur Radiol 28:4086\u20134101","journal-title":"Eur Radiol"},{"key":"1064_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.rcl.2021.05.009","volume":"59","author":"PP Manapragada","year":"2021","unstructured":"Manapragada\u00a0PP, Andrikopoulou\u00a0E, Bajaj\u00a0N et\u00a0al (2021) PET cardiac imaging (perfusion, viability, sarcoidosis, and infection). Radiol Clin North Am 59:835\u2013852","journal-title":"Radiol Clin North Am"},{"key":"1064_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1148\/radiol.13130231","volume":"268","author":"F Nensa","year":"2013","unstructured":"Nensa\u00a0F, Poeppel\u00a0TD, Beiderwellen\u00a0K et\u00a0al (2013) Hybrid PET\/MR imaging of the heart: feasibility and initial results. Radiology 268:366\u2013373","journal-title":"Radiology"},{"key":"1064_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti\u00a0J, Wijns\u00a0W, Saraste\u00a0A et\u00a0al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart\u00a0J 41:407\u2013477","journal-title":"Eur Heart J"},{"key":"1064_CR5","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.1016\/j.crvasa.2015.08.007","volume":"57","author":"S Greulich","year":"2015","unstructured":"Greulich\u00a0S, Sechtem\u00a0U (2015) Multimodality imaging in coronary artery disease\u2014\u201cthe more the better?\u201d. Cor Vasa 57:e462\u2013e469","journal-title":"Cor Vasa"},{"key":"1064_CR6","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/s12350-012-9607-9","volume":"19","author":"S Raja","year":"2012","unstructured":"Raja\u00a0S, Singh\u00a0B, Rohit\u00a0MK et al (2012) Comparison of nitrate augmented Tc-99m tetrofosmin gated SPECT imaging with FDG PET imaging for the assessment of myocardial viability in patients with severe left ventricular dysfunction. J\u00a0Nucl Cardiol 19:1176\u20131181","journal-title":"J Nucl Cardiol"},{"key":"1064_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5152\/dir.2014.14008","volume":"20","author":"F Nensa","year":"2020","unstructured":"Nensa\u00a0F, Beiderwellen\u00a0K, Heusch\u00a0P et\u00a0al (2020) Clinical applications of PET\/MRI: current status and future perspectives. Diagn Interv Radiol 20:438\u2013447","journal-title":"Diagn Interv Radiol"},{"key":"1064_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2022.877364","volume":"9","author":"D Filomena","year":"2022","unstructured":"Filomena\u00a0D, Dresselaers\u00a0T, Bogaert\u00a0J (2022) Role of cardiovascular magnetic resonance to assess cardiovascular inflammation. Front Cardiovasc Med 9:1\u201318","journal-title":"Front Cardiovasc Med"},{"key":"1064_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"O Manabe","year":"2016","unstructured":"Manabe\u00a0O, Yoshinaga\u00a0K, Ohira\u00a0H et al (2016) The effects of 18\u2011h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoid. J\u00a0Nucl Cardiol 23:244\u2013252","journal-title":"J Nucl Cardiol"},{"key":"1064_CR10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s12350-016-0443-1","volume":"24","author":"F Nensa","year":"2017","unstructured":"Nensa\u00a0F, Tezgah\u00a0E, Schweins\u00a0K et al (2017) Evaluation of a\u00a0low-carbohydrate diet-based preparation protocol without fasting for cardiac PET\/MR imaging. J\u00a0Nucl Cardiol 24:980\u2013988","journal-title":"J Nucl Cardiol"},{"key":"1064_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","volume":"11","author":"MR Dweck","year":"2018","unstructured":"Dweck\u00a0MR, Abgral\u00a0R, Trivieri\u00a0MG et\u00a0al (2018) Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis. J Am Coll Cardiol Img 11:94\u2013107","journal-title":"J Am Coll Cardiol Img"},{"key":"1064_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jcmg.2021.08.018","volume":"15","author":"S Greulich","year":"2022","unstructured":"Greulich\u00a0S, Gatidis\u00a0S, Gr\u00e4ni\u00a0C et\u00a0al (2022) Hybrid cardiac magnetic resonance\/fluorodeoxyglucose positron emission tomography to differentiate active from chronic cardiac sarcoidosis. J Am Coll Cardiol Img 15:445\u2013456","journal-title":"J Am Coll Cardiol Img"},{"key":"1064_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","volume":"6","author":"S Greulich","year":"2013","unstructured":"Greulich\u00a0S, Deluigi\u00a0CC, Gloekler\u00a0S et\u00a0al (2013) CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. J Am Coll Cardiol Img 6:501\u2013511","journal-title":"J Am Coll Cardiol Img"},{"key":"1064_CR14","doi-asserted-by":"publisher","first-page":"e015351","DOI":"10.1161\/JAHA.119.015351","volume":"9","author":"S Greulich","year":"2020","unstructured":"Greulich\u00a0S, Seitz\u00a0A, M\u00fcller\u00a0KAL et al (2020) Predictors of mortality in patients with biopsy-proven viral myocarditis: 10-year outcome data. J\u00a0Am Heart Assoc 9:e15351","journal-title":"J Am Heart Assoc"},{"key":"1064_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-020-00610-6","volume":"22","author":"J Schulz-Menger","year":"2020","unstructured":"Schulz-Menger\u00a0J, Bluemke\u00a0DA, Bremerich\u00a0J et al (2020) Standardized image interpretation and post-processing in cardiovascular magnetic resonance\u20142020 update. J\u00a0Cardiovasc Magn Reson 22:1\u201322","journal-title":"J Cardiovasc Magn Reson"},{"key":"1064_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1055\/s-0032-1313171","volume":"184","author":"M Groth","year":"2012","unstructured":"Groth\u00a0M, Muellerleile\u00a0K, Klink\u00a0T et\u00a0al (2012) Improved agreement between experienced and inexperienced observers using a\u00a0standardized evaluation protocol for cardiac volumetry and infarct size measurement. Fortschr R\u00f6ntgenstr 184:1131\u20131137","journal-title":"Fortschr R\u00f6ntgenstr"},{"key":"1064_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12350-020-02359-y","volume":"29","author":"M Okune","year":"2022","unstructured":"Okune\u00a0M, Yasuda\u00a0M, Soejima\u00a0N et al (2022) Diagnostic utility of fusion 18F-fluorodeoxyglucose positron emission tomography\/cardiac magnetic resonance imaging in cardiac sarcoidosis. J\u00a0Nucl Cardiol 29:753\u2013764","journal-title":"J Nucl Cardiol"},{"key":"1064_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11604-018-0727-2","volume":"36","author":"P Krumm","year":"2018","unstructured":"Krumm\u00a0P, Mangold\u00a0S, Gatidis\u00a0S et al (2018) Clinical use of cardiac PET\/MRI: current state-of-the-art and potential future applications. Jpn J Radiol 36:313\u2013323","journal-title":"Jpn J Radiol"},{"key":"1064_CR19","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1097\/RLU.0000000000001669","volume":"42","author":"K Hanneman","year":"2017","unstructured":"Hanneman\u00a0K, Kadoch\u00a0M, Guo\u00a0HH et al (2017) Initial experience with simultaneous 18F-FDG PET\/MRI in the evaluation of cardiac sarcoidosis and myocarditis. Clin Nucl Med 42:e328\u2013e334","journal-title":"Clin Nucl Med"},{"key":"1064_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/ehjci\/jex340","volume":"19","author":"EC Wicks","year":"2018","unstructured":"Wicks\u00a0EC, Menezes\u00a0LJ, Barnes\u00a0A et al (2018) Diagnostic accuracy and prognostic value of simultaneous hybrid 18\u202fF-fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging 19:757\u2013767","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1064_CR21","doi-asserted-by":"publisher","first-page":"e007405","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405","volume":"13","author":"E Ammirati","year":"2020","unstructured":"Ammirati\u00a0E, Frigerio\u00a0M, Adler\u00a0ED et\u00a0al (2020) Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail 13:e007405","journal-title":"Circ Heart Fail"},{"key":"1064_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-022-02639-0","volume":"22","author":"E Bobbio","year":"2022","unstructured":"Bobbio\u00a0E, Hjalmarsson\u00a0C, Bj\u00f6rkenstam\u00a0M et\u00a0al (2022) Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a\u00a0Swedish single center experience. BMC Cardiovasc Disord 22:1\u201310","journal-title":"BMC Cardiovasc Disord"},{"key":"1064_CR23","doi-asserted-by":"publisher","first-page":"e190140","DOI":"10.1148\/ryct.2020190140","volume":"2","author":"RA Coulden","year":"2020","unstructured":"Coulden\u00a0RA, Sonnex\u00a0EP, Abele\u00a0JT et\u00a0al (2020) Utility of FDG PET and cardiac MRI in diagnosis and monitoring of immunosuppressive treatment in cardiac sarcoidosis. Radiol Cardiothorac Imaging 2:e190140","journal-title":"Radiol Cardiothorac Imaging"},{"key":"1064_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41824-021-00119-w","volume":"5","author":"E Cheung","year":"2021","unstructured":"Cheung\u00a0E, Ahmad\u00a0S, Aitken\u00a0M et al (2021) Combined simultaneous FDG-PET\/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis. Eur J Hybrid Imaging 5:24","journal-title":"Eur J Hybrid Imaging"},{"key":"1064_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/14779072.2018.1455499","volume":"16","author":"VO Puntmann","year":"2018","unstructured":"Puntmann\u00a0VO, Zeiher\u00a0AM, Nagel\u00a0E (2018) T1 and T2 mapping in myocarditis: seeing beyond the horizon of Lake Louise criteria and histopathology. Expert Rev Cardiovasc Ther 16:319\u2013330","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"1064_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/diagnostics12020399","volume":"12","author":"CL Polte","year":"2022","unstructured":"Polte\u00a0CL, Bobbio\u00a0E, Bollano\u00a0E et\u00a0al (2022) Cardiovascular magnetic resonance in myocarditis. Diagnostics 12:399","journal-title":"Diagnostics"},{"key":"1064_CR27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1055\/a-1539-8664","volume":"41","author":"S Greulich","year":"2021","unstructured":"Greulich\u00a0S, Klingel\u00a0K (2021) COVID-19 and myocarditis: findings from cardiac magnetic resonance imaging and endomyocardial biopsies. Hamostaseologie 41:366\u2013370","journal-title":"Hamostaseologie"},{"key":"1064_CR28","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.jacc.2017.08.050","volume":"70","author":"C Gr\u00e4ni","year":"2017","unstructured":"Gr\u00e4ni\u00a0C, Eichhorn\u00a0C, Bi\u00e8re\u00a0L et\u00a0al (2017) Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J\u00a0Am Coll Cardiol 70:1964\u20131976","journal-title":"J Am Coll Cardiol"},{"key":"1064_CR29","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.jacc.2017.08.062","volume":"70","author":"H Mahrholdt","year":"2017","unstructured":"Mahrholdt\u00a0H, Greulich\u00a0S (2017) Prognosis in myocarditis: better late than (n)ever! J\u00a0Am Coll Cardiol 70:1988\u20131990","journal-title":"J Am Coll Cardiol"},{"key":"1064_CR30","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcmg.2021.11.017","volume":"15","author":"C Eichhorn","year":"2022","unstructured":"Eichhorn\u00a0C, Greulich\u00a0S, Bucciarelli-Ducci\u00a0C et al (2022) Multiparametric cardiovascular magnetic resonance approach in diagnosing, monitoring, and prognostication of myocarditis. J Am Coll Cardiol Img 15:1325\u20131338","journal-title":"J Am Coll Cardiol Img"},{"key":"1064_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12410-015-9320-6","volume":"8","author":"S Greulich","year":"2015","unstructured":"Greulich\u00a0S, Ferreira\u00a0VM, Dall\u2019Armellina\u00a0E et\u00a0al (2015) Myocardial inflammation \u2013 are we there yet? Curr Cardiovasc Imaging Rep 8:6","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"1064_CR32","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira\u00a0VM, Schulz-Menger\u00a0J, Holmvang\u00a0G et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J\u00a0Am Coll Cardiol 72:3158\u20133176","journal-title":"J Am Coll Cardiol"},{"key":"1064_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s12410-022-09566-w","author":"C Garc\u00eda Sebasti\u00e1n","year":"2022","unstructured":"Garc\u00eda Sebasti\u00e1n\u00a0C, Hinojar Bayd\u00e9s\u00a0R, Zamorano G\u00f3mez\u00a0JL et\u00a0al (2022) Cardiac magnetic resonance for myocardial inflammation: current state and future directions. Curr Cardiovasc Imaging Rep. https:\/\/doi.org\/10.1007\/s12410-022-09566-w","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"1064_CR34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s12350-016-0616-y","volume":"25","author":"F Nensa","year":"2018","unstructured":"Nensa\u00a0F, Kloth\u00a0J, Tezgah\u00a0E et al (2018) Feasibility of FDG-PET in myocarditis: comparison to CMR using integrated PET\/MRI. J\u00a0Nucl Cardiol 25:785\u2013794","journal-title":"J Nucl Cardiol"},{"key":"1064_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ijcard.2021.02.068","volume":"332","author":"K Oziera\u0144ski","year":"2021","unstructured":"Oziera\u0144ski\u00a0K, Tymi\u0144ska\u00a0A, Kobylecka\u00a0M et\u00a0al (2021) Positron emission tomography in clinically suspected myocarditis\u2014STREAM study design. Int J Cardiol 332:113\u2013118","journal-title":"Int J Cardiol"},{"key":"1064_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11886-019-1158-0","volume":"21","author":"W Chen","year":"2019","unstructured":"Chen\u00a0W, Jeudy\u00a0J (2019) Assessment of myocarditis: cardiac MR, PET\/CT, or PET\/MR? Curr Cardiol Rep 21:76","journal-title":"Curr Cardiol Rep"}],"container-title":["Die Radiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-022-01064-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-022-01064-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-022-01064-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T08:04:07Z","timestamp":1666857847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-022-01064-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1007\/s00117-022-01064-w","relation":{},"ISSN":["2731-7048","2731-7056"],"issn-type":[{"type":"print","value":"2731-7048"},{"type":"electronic","value":"2731-7056"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"1 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Krumm, S.\u00a0Greulich, C.\u00a0la Foug\u00e8re und K.\u00a0Nikolaou geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}